Skandinaviska Enskilda Banken AB (publ) - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 134 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$4,973,000
+30.4%
332,000
+5.9%
0.06%
+30.2%
Q1 2016$3,815,000
-39.7%
313,500
-21.4%
0.04%
-47.6%
Q4 2015$6,323,000398,9000.08%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 462,824$7,364,0008.63%
HealthCor Management, L.P. 1,750,000$27,843,0001.69%
ACUTA CAPITAL PARTNERS, LLC 144,667$2,302,0001.10%
THB ASSET MANAGEMENT 615,546$9,793,0001.05%
Penn Capital Management Company, LLC 1,399,205$22,261,0000.98%
Tamarack Advisers, LP 450,000$7,160,0000.94%
Piermont Capital Management Inc. 139,020$2,212,0000.70%
JW Asset Management, LLC 101,630$1,617,0000.60%
SECTORAL ASSET MANAGEMENT INC 810,362$12,893,0000.55%
Glacier Peak Capital LLC 50,000$796,0000.51%
View complete list of SAGENT PHARMACEUTICALS INC shareholders